Literature DB >> 16130105

Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke.

James F Meschia1, Thomas G Brott, Robert D Brown, Richard Crook, Bradford B Worrall, Brett Kissela, W Mark Brown, Stephen S Rich, L Douglas Case, E Whitney Evans, Stephen Hague, Andrew Singleton, John Hardy.   

Abstract

Risk for ischemic stroke is mediated by both environmental and genetic factors. Although several environmental exposures have been implicated, relatively little is known about the genetic basis of predisposition to this disease. Recent studies in Iceland identified risk polymorphisms in two putative candidate genes for ischemic stroke: phosphodiesterase 4D (PDE4D) and 5-lipoxygenase activating protein (ALOX5AP). A collection of North American sibling pairs concordant for ischemic stroke and two cohorts of prospectively ascertained North American ischemic stroke cases and control subjects were used for evaluation of PDE4D and ALOX5AP. Although no evidence supported linkage of ischemic stroke with either of the two candidate genes, single-nucleotide polymorphisms and haplotypic associations were observed between PDE4D and ischemic stroke. There was no evidence of association between variants of ALOX5AP and ischemic stroke. These data suggest that common variants in PDE4D may contribute to the genetic risk for ischemic stroke in multiple populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16130105      PMCID: PMC1774984          DOI: 10.1002/ana.20585

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

1.  VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors.

Authors:  Laure Favot; Thérèse Keravis; Vincent Holl; Alain Le Bec; Claire Lugnier
Journal:  Thromb Haemost       Date:  2003-08       Impact factor: 5.249

2.  Chlamydophila pneumoniae induces p44/p42 mitogen-activated protein kinase activation in human fibroblasts through Toll-like receptor 4.

Authors:  Iana H Haralambieva; Ianko D Iankov; Petya V Ivanova; Vanio Mitev; Ivan G Mitov
Journal:  J Med Microbiol       Date:  2004-12       Impact factor: 2.472

3.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  Mortality by cause for eight regions of the world: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

5.  Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation.

Authors:  Miyako Ariga; Barbara Neitzert; Susumu Nakae; Genevieve Mottin; Claude Bertrand; Marie Pierre Pruniaux; S-L Catherine Jin; Marco Conti
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

6.  Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4.

Authors:  Laure Favot; Thérèse Keravis; Claire Lugnier
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

7.  Type 4 phosphodiesterase-dependent pathways: role in inflammatory processes.

Authors:  C Jacob; C Martin-Chouly; V Lagente
Journal:  Therapie       Date:  2002 Mar-Apr       Impact factor: 2.070

8.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

9.  Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989.

Authors:  R D Brown; J P Whisnant; J D Sicks; W M O'Fallon; D O Wiebers
Journal:  Stroke       Date:  1996-03       Impact factor: 7.914

10.  Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

Authors:  P M Rothwell; A J Coull; M F Giles; S C Howard; L E Silver; L M Bull; S A Gutnikov; P Edwards; D Mant; C M Sackley; A Farmer; P A G Sandercock; M S Dennis; C P Warlow; J M Bamford; P Anslow
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

View more
  38 in total

Review 1.  Approaching biomarker discovery through genomics.

Authors:  Stephen S Rich
Journal:  J Cardiovasc Transl Res       Date:  2008-01-26       Impact factor: 4.132

2.  A tagging SNP in ALOX5AP and risk of stroke: a haplotype-based analysis among eastern Chinese Han population.

Authors:  Hao Sun; Hao Wu; Jing Zhang; Jun Wang; Ying Lu; Haixia Ding; Hang Xiao; Jinsong Zhang
Journal:  Mol Biol Rep       Date:  2010-12-14       Impact factor: 2.316

3.  A large-sample assessment of possible association between ischaemic stroke and rs12188950 in the PDE4D gene.

Authors:  Håkan Lövkvist; Sandra Olsson; Peter Höglund; Olle Melander; Christina Jern; Marketa Sjögren; Gunnar Engström; J Gustav Smith; Bo Hedblad; Gunnar Andsberg; Hossein Delavaran; Katarina Jood; Ulf Kristoffersson; Holger Luthman; Bo Norrving; Arne Lindgren
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 4.  PDE4D and stroke: a real advance or a case of the Emperor's new clothes?

Authors:  Bradford B Worrall; Josyf C Mychaleckyj
Journal:  Stroke       Date:  2006-07-06       Impact factor: 7.914

5.  Structural genomic variation in ischemic stroke.

Authors:  Mar Matarin; Javier Simon-Sanchez; Hon-Chung Fung; Sonja Scholz; J Raphael Gibbs; Dena G Hernandez; Cynthia Crews; Angela Britton; Fabienne Wavrant De Vrieze; Thomas G Brott; Robert D Brown; Bradford B Worrall; Scott Silliman; L Douglas Case; John A Hardy; Stephen S Rich; James F Meschia; Andrew B Singleton
Journal:  Neurogenetics       Date:  2008-02-21       Impact factor: 2.660

6.  Genetic polymorphisms of T-1131C APOA5 and ALOX5AP SG13S114 with the susceptibility of ischaemic stroke in Morocco.

Authors:  Brehima Diakite; Khalil Hamzi; Wiam Hmimech; Sellama Nadifi
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

7.  Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk.

Authors:  Mahmoud Merhi; Sally Demirdjian; Essa Hariri; Nada Sabbah; Sonia Youhanna; Michella Ghassibe-Sabbagh; Joseph Naoum; Marc Haber; Raed Othman; Samer Kibbani; Elie Chammas; Roy Kanbar; Hamid El Bayeh; Youssef Chami; Antoine Abchee; Daniel E Platt; Pierre Zalloua; Georges Khazen
Journal:  Inflamm Res       Date:  2015-04-24       Impact factor: 4.575

8.  The SG13S114 polymorphism of the ALOX5AP gene is associated with ischemic stroke in Europeans: a meta-analysis of 8062 subjects.

Authors:  Zhongjun Chen; Jinyu Zheng; Wenguang Liu; Kun Yang; Kai Li; Baosheng Huang; Ronglan Zhu; Xiaocheng Lu; Lixin Li
Journal:  Neurol Sci       Date:  2017-01-18       Impact factor: 3.307

Review 9.  Genetic and genomic insights into the molecular basis of atherosclerosis.

Authors:  Yaoyu Chen; Jarod Rollins; Beverly Paigen; Xiaosong Wang
Journal:  Cell Metab       Date:  2007-09       Impact factor: 27.287

10.  Leukotriene A4 hydrolase haplotype, diet and atherosclerosis: a twin study.

Authors:  Jinying Zhao; Jack Goldberg; Viola Vaccarino
Journal:  Atherosclerosis       Date:  2012-10-31       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.